Knight Therapeutics
Knight Therapeutics Inc. · GUD (TSX) · Montreal, QC · Pharmaceuticals
Latest R&D (CAD)
$29.0M
Period ended 2025-12-31
Revenue (CAD)
$450.1M
Intensity 6.4%
R&D by fiscal period
2025
$29.0M
2024
$23.3M
| Period end | R&D (CAD) | Revenue (CAD) | Native R&D | Form | Source |
|---|---|---|---|---|---|
| 2025-12-31 | $28,984,000 | $450,088,000 | $28,984,000 CAD | Year-end results | Annual report |
| 2024-12-31 | $23,304,000 | $371,304,000 | $23,304,000 CAD | Year-end results | Annual report |